Abstract:Hydrogen sulfide (H2S) is an important gaseous signaling molecule that serves many important regulatory roles in physiological and pathophysiological conditions. H2S exerts an anti-atherosclerotic effect through mediating the biological functions of nitric oxide (NO). However, its mechanism of action is unclear. The purpose of this study is to explore the effect mechanism of H2S on the development of atherosclerosis with regard to protein S-nitrosylation. A total of 45 male apoE-/- mice were randomly divided into three groups. Atherosclerosis was induced by Western diet (21% fat and 0.15% cholesterol) with/without administration of a H2S donor (NaHS) or an endogenous cystathionine γ-lyase inhibitor (d, l-propargylglycine) for 12 weeks. After 12 weeks, plasma lipid and plasma NO levels were measured. Aortic gross lesion area and histopathological features of aortic lesion were determined. Additionally, the level of S-nitrosylated proteins in vascular smooth muscle cells (VSMCs) was detected using immunofluorescence in aorta. Rat VSMCs were performed in an in vitro experiment. Inducible nitric oxide synthase (iNOS) protein expression, NO generation, protein S-nitrosylation, and cell proliferation and migration were measured. We found that H2S significantly reduced the aortic atherosclerotic lesion area (P=0.006) and inhibited lipid and macrophage accumulation (P=0.004, P=0.002) and VSMC proliferation (P=0.019) in apoE-/- mice. H2S could up-regulate levels of plasma NO and protein S-nitrosylation in aorta VSMCs. However, d, l- propargylglycine had the opposite effect, increasing the lesion area and the content of lipids and macrophages in the lesions of apoE-/- mice and down-regulating plasma NO levels and protein S-nitrosylation in aorta VSMCs. In vitro experiments, H2S could significantly reverse the reduction of iNOS expression and NO generation induced by oxidized low-density lipoprotein in VSMCs. Moreover, H2S could increase the protein S-nitrosylation level of VSMCs in a dose-dependent manner, and the effect could be inhibited by iNOS inhibitors. In addition, proliferation and migration of VSMCs could be inhibited by H2S in a dose-dependent manner, which could be blocked by an iNOS inhibitor or protein S-nitrosylation removal agent. Our data suggest that H2S could inhibit the development of atherosclerosis by up-regulating plasma NO and protein S-nitrosylation, thereby inhibiting the proliferation and migration of VSMCs.

Effects of gut microbiota on atherosclerosis through hydrogen sulfide

The Gut Microbiota-Artery Axis: A Bridge Between Dietary Lipids and Atherosclerosis?

Atherosclerosis And The Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches To Disease Prevention

Endogenous Hydrogen Sulfide Is Involved In The Pathogenesis Of Atherosclerosis

EndMT: Potential Target of H2S against Atherosclerosis

Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.

Study Progress of Gasotransmitter Hydrogen Sulfide and Cardiovascular Diseases

The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: from Molecular Mechanisms to Therapeutic Potential

Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases

Effects of salidroside on atherosclerosis: potential contribution of gut microbiota

Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?

A Newly Found Gasotransmitter, Hydrogen Sulfide, in the Pathogenesis of Hypertension and Other Cardiovascular Diseases

The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives

Hydrogen Sulfide Modulation of Matrix Metalloproteinases and CD147/EMMPRIN: Mechanistic Pathways and Impact on Atherosclerosis Progression

Hydrogen Sulfide Inhibits Development of Atherosclerosis Through Up-Regulating Protein S-nitrosylation.

Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide

Effect of Hydrogen Sulfide on the Development and Progression of Atherosclerosis with Respect to Chemokine Receptor CX3CR1 Expression in Plaques

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases

Role of Cystathionine Gamma-Lyase/Hydrogen Sulfide Pathway in Cardiovascular Disease: A Novel Therapeutic Strategy?

Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: an Overview with Update on Immunomodulation